XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results | British Journal of Cancer
The prognostic effect of adjuvant chemotherapy in the colon cancer patients with solitary lymph node metastasis | International Journal of Colorectal Disease
Adjuvant chemotherapy for colorectal cancer - ScienceDirect
3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
CAPOX - Wikipedia
Median cycle of XELOX adjuvant chemotherapy received by patients for... | Download Scientific Diagram
Metachronous pulmonary and pancreatic metastases arising from sigmoid colon cancer: A case report
JCM | Free Full-Text | The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
IJMS | Free Full-Text | Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer
Oral adjuvant therapy for colorectal cancer: recent developments and future targets | Therapeutic Delivery
Schéma de l'étude AVANT - ppt télécharger
Table 1 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials - ScienceDirect
Adjuvant Therapy for Locoregional Colon Cancer (Slides With Transcript)
The Adjuvant Treatment of Stage III Colon Cancer: Might Less Be More?
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial - The Lancet Oncology
Trials With XELOX-Based Neoadjuvant Chemoradiotherapy With or Without... | Download Table
Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline | Journal of Clinical Oncology
Bevacizumab (Bev) in combination with XELOX or FOLFOX-4: updated efficacy results from XELOX-1 / NO16966, a randomized phase III trial in first-line metastatic. - ppt video online download
Cancers | Free Full-Text | Adjuvant Chemotherapy for Stage III Colon Cancer
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer | NEJM
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials - The Lancet Oncology
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
